RGS4 Is Required for Dopaminergic Control of Striatal LTD and Susceptibility to Parkinsonian Motor Deficits

Plasticity of excitatory synapses onto striatal projection neurons (MSNs) has the potential to regulate motor function by setting the gain on signals driving both direct- and indirect-pathway basal ganglia circuits. Endocannabinoid-dependent long-term depression (eCB-LTD) is the best characterized form of striatal plasticity, but the mechanisms governing its normal regulation and pathological dysregulation are not well understood. We characterized two distinct signaling pathways mediating eCB production in striatal indirect-pathway MSNs and found that both pathways were modulated by dopamine D2 and adenosine A2A receptors, acting through cAMP/PKA. We identified regulator of G protein signaling 4 (RGS4) as a key link between D2/A2A signaling and eCB mobilization pathways. In contrast to wild-type mice, RGS4⁻/⁻ mice exhibited normal eCB-LTD after dopamine depletion and were significantly less impaired in the 6-OHDA model of Parkinson's disease. Taken together, these results suggest that inhibition of RGS4 may be an effective nondopaminergic strategy for treating Parkinson's disease.

[1]  D. Lovinger,et al.  Combined Activation of L-Type Ca2+ Channels and Synaptic Transmission Is Sufficient to Induce Striatal Long-Term Depression , 2007, The Journal of Neuroscience.

[2]  D. Lovinger,et al.  Decreased probability of neurotransmitter release underlies striatal long-term depression and postnatal development of corticostriatal synapses. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[3]  P. Calabresi,et al.  Interaction of A2A adenosine and D2 dopamine receptors modulates corticostriatal glutamatergic transmission , 2007, Neuropharmacology.

[4]  Hee-Sup Shin,et al.  Phospholipase Cβ Serves as a Coincidence Detector through Its Ca2+ Dependency for Triggering Retrograde Endocannabinoid Signal , 2005, Neuron.

[5]  D. Piomelli.  The molecular logic of endocannabinoid signalling , 2003, Nature Reviews Neuroscience.

[6]  J. McGinty,et al.  Regulator of G-Protein Signaling 4 Interacts with Metabotropic Glutamate Receptor Subtype 5 in Rat Striatum: Relevance to Amphetamine Behavioral Sensitization , 2007, Journal of Pharmacology and Experimental Therapeutics.

[7]  Thomas Wichmann,et al.  Circuits and circuit disorders of the basal ganglia. , 2007, Archives of neurology.

[8]  J. Hepler,et al.  Cell signalling diversity of the Gqα family of heterotrimeric G proteins , 2006 .

[9]  P. Calabresi,et al.  Post-receptor mechanisms underlying striatal long-term depression , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[10]  Joshua L. Plotkin,et al.  Dopamine and synaptic plasticity in dorsal striatal circuits controlling action selection , 2009, Current Opinion in Neurobiology.

[11]  A M Graybiel,et al.  The basal ganglia and adaptive motor control. , 1994, Science.

[12]  S. J. Taylor,et al.  Activation of the beta 1 isozyme of phospholipase C by alpha subunits of the Gq class of G proteins. , 1991, Nature.

[13]  Xin-Yun Huang,et al.  Direct stimulation of Bruton's tyrosine kinase by Gq-protein α-subunit , 1997, Nature.

[14]  Anatol C. Kreitzer,et al.  Striatal Plasticity and Basal Ganglia Circuit Function , 2008, Neuron.

[15]  K. Fuxe,et al.  Adenosine A2A receptors, dopamine D2 receptors and their interactions in Parkinson's disease , 2007 .

[16]  B. Cravatt,et al.  Enzymatic Pathways that Regulate Endocannabinoid Signaling in the Nervous System , 2008 .

[17]  Stephen B. Dunnett,et al.  Characterization of Progressive Motor Deficits in Mice Transgenic for the Human Huntington’s Disease Mutation , 1999, The Journal of Neuroscience.

[18]  Yihui Cui,et al.  Distinct coincidence detectors govern the corticostriatal spike timing‐dependent plasticity , 2010, The Journal of physiology.

[19]  P. Conn,et al.  RGS4 Inhibits Signaling by Group I Metabotropic Glutamate Receptors , 1998, The Journal of Neuroscience.

[20]  K. Fuxe,et al.  Adenosine A(2A) receptors, dopamine D(2) receptors and their interactions in Parkinson's disease. , 2007, Movement disorders : official journal of the Movement Disorder Society.

[21]  H. Yin,et al.  The role of the basal ganglia in habit formation , 2006, Nature Reviews Neuroscience.

[22]  J. Maloteaux,et al.  Altered expression of regulators of G-protein signaling (RGS) mRNAs in the striatum of rats undergoing dopamine depletion. , 2003, Biochemical pharmacology.

[23]  T. Kozasa,et al.  Direct stimulation of Bruton's tyrosine kinase by G(q)-protein alpha-subunit. , 1997, Nature.

[24]  Luigi F. Agnati,et al.  Adenosine A2A and dopamine D2 heteromeric receptor complexes and their function , 2007, Journal of Molecular Neuroscience.

[25]  Douglas R. Porter,et al.  Impaired dopamine release and synaptic plasticity in the striatum of PINK1-deficient mice , 2007, Proceedings of the National Academy of Sciences.

[26]  Jonathan Salcedo,et al.  Early and Progressive Sensorimotor Anomalies in Mice Overexpressing Wild-Type Human α-Synuclein , 2004, The Journal of Neuroscience.

[27]  K. Murthy,et al.  Inhibition of G (cid:1) q -dependent PLC- (cid:2) 1 activity by PKG and PKA is mediated by phosphorylation of RGS4 and GRK2 , 2007 .

[28]  K. Mackie,et al.  Stimulation of Endocannabinoid Formation in Brain Slice Cultures through Activation of Group I Metabotropic Glutamate Receptors , 2005, Molecular Pharmacology.

[29]  K. Henkels,et al.  A Comprehensive Model That Explains the Regulation of Phospholipase D2 Activity by Phosphorylation-Dephosphorylation , 2010, Molecular and Cellular Biology.

[30]  P. Calabresi,et al.  A53T-Alpha-Synuclein Overexpression Impairs Dopamine Signaling and Striatal Synaptic Plasticity in Old Mice , 2010, PloS one.

[31]  R. Neubig,et al.  Reversible, Allosteric Small-Molecule Inhibitors of Regulator of G Protein Signaling Proteins , 2010, Molecular Pharmacology.

[32]  D. Lovinger,et al.  Frequency-specific and D2 receptor-mediated inhibition of glutamate release by retrograde endocannabinoid signaling. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[33]  K. Murthy,et al.  Inhibition of Galphaq-dependent PLC-beta1 activity by PKG and PKA is mediated by phosphorylation of RGS4 and GRK2. , 2007, American journal of physiology. Cell physiology.

[34]  M. Chesselet,et al.  Early and progressive sensorimotor anomalies in mice overexpressing wild-type human alpha-synuclein. , 2004, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[35]  Charles J. Wilson,et al.  RGS4-dependent attenuation of M4 autoreceptor function in striatal cholinergic interneurons following dopamine depletion , 2006, Nature Neuroscience.

[36]  P. Calabresi,et al.  The Distinct Role of Medium Spiny Neurons and Cholinergic Interneurons in the D2/A2A Receptor Interaction in the Striatum: Implications for Parkinson's Disease , 2011, The Journal of Neuroscience.

[37]  Anatol C. Kreitzer,et al.  Dopamine Modulation of State-Dependent Endocannabinoid Release and Long-Term Depression in the Striatum , 2005, The Journal of Neuroscience.

[38]  L. Tremblay,et al.  Abnormal spontaneous activity of globus pallidus neurons in monkeys with MPTP-induced parkinsonism , 1991, Brain Research.

[39]  P. Greengard,et al.  Dichotomous Dopaminergic Control of Striatal Synaptic Plasticity , 2008, Science.

[40]  P. Calabresi,et al.  Abnormal Synaptic Plasticity in the Striatum of Mice Lacking Dopamine D2 Receptors , 1997, The Journal of Neuroscience.

[41]  Talia N. Lerner,et al.  Neuromodulatory control of striatal plasticity and behavior , 2011, Current Opinion in Neurobiology.

[42]  O. Hikosaka,et al.  Role of the basal ganglia in the control of purposive saccadic eye movements. , 2000, Physiological reviews.

[43]  J. Bolam,et al.  Synaptic organisation of the basal ganglia , 2000, Journal of anatomy.

[44]  M. Pangalos,et al.  Loss of Retrograde Endocannabinoid Signaling and Reduced Adult Neurogenesis in Diacylglycerol Lipase Knock-out Mice , 2010, The Journal of Neuroscience.

[45]  Masahiko Watanabe,et al.  Subcellular Arrangement of Molecules for 2-Arachidonoyl-Glycerol-Mediated Retrograde Signaling and Its Physiological Contribution to Synaptic Modulation in the Striatum , 2007, The Journal of Neuroscience.

[46]  X. Zhuang,et al.  Adenylyl Cyclase Type 5 Contributes to Corticostriatal Plasticity and Striatum-Dependent Learning , 2009, The Journal of Neuroscience.

[47]  Talia N. Lerner,et al.  Endocannabinoid Signaling Mediates Psychomotor Activation by Adenosine A2A Antagonists , 2010, The Journal of Neuroscience.

[48]  Robert C. Malenka,et al.  Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models , 2007, Nature.

[49]  Henry H. Yin,et al.  Dopaminergic Control of Corticostriatal Long-Term Synaptic Depression in Medium Spiny Neurons Is Mediated by Cholinergic Interneurons , 2006, Neuron.

[50]  B. Knowlton,et al.  Learning and memory functions of the Basal Ganglia. , 2002, Annual review of neuroscience.

[51]  J. Hepler,et al.  Cell signalling diversity of the Gqalpha family of heterotrimeric G proteins. , 2006, Cellular signalling.

[52]  D. Lovinger,et al.  Induction of striatal long‐term synaptic depression by moderate frequency activation of cortical afferents in rat , 2005, The Journal of physiology.

[53]  F. Middleton,et al.  Transcriptional analysis of multiple brain regions in Parkinson's disease supports the involvement of specific protein processing, energy metabolism, and signaling pathways, and suggests novel disease mechanisms , 2005, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[54]  J. McGinty,et al.  Chronic cocaine reduces RGS4 mRNA in rat prefrontal cortex and dorsal striatum , 2007, Neuroreport.

[55]  D. Lovinger,et al.  Activation of group I mGluRs is necessary for induction of long-term depression at striatal synapses. , 2001, Journal of neurophysiology.

[56]  R. Neubig,et al.  A nanomolar-potency small molecule inhibitor of regulator of G-protein signaling proteins. , 2011, Biochemistry.

[57]  Mauro Delorenzi,et al.  Mutant huntingtin's effects on striatal gene expression in mice recapitulate changes observed in human Huntington's disease brain and do not differ with mutant huntingtin length or wild-type huntingtin dosage. , 2007, Human molecular genetics.

[58]  M. Delong,et al.  Pathophysiologic basis of surgery for Parkinson's disease. , 2000, Neurology.

[59]  J. Leysen,et al.  Dopamine receptor‐mediated regulation of RGS2 and RGS4 mRNA differentially depends on ascending dopamine projections and time , 2004, The European journal of neuroscience.

[60]  Kristen K. Ade,et al.  Anandamide Regulates Postnatal Development of Long-Term Synaptic Plasticity in the Rat Dorsolateral Striatum , 2007, The Journal of Neuroscience.

[61]  Kendra K Bence-Hanulec,et al.  Potentiation of Neuronal L Calcium Channels by IGF-1 Requires Phosphorylation of the α1 Subunit on a Specific Tyrosine Residue , 2000, Neuron.

[62]  Masahiko Watanabe,et al.  The Endocannabinoid 2-Arachidonoylglycerol Produced by Diacylglycerol Lipase α Mediates Retrograde Suppression of Synaptic Transmission , 2010, Neuron.

[63]  T. Sejnowski,et al.  Convergent evidence for abnormal striatal synaptic plasticity in dystonia , 2010, Neurobiology of Disease.

[64]  E. Nestler,et al.  Regulators of G-Protein Signaling (RGS) Proteins: Region-Specific Expression of Nine Subtypes in Rat Brain , 1997, The Journal of Neuroscience.

[65]  J. Bockaert,et al.  Functional coupling between ryanodine receptors and L-type calcium channels in neurons , 1996, Nature.

[66]  A. Pisani,et al.  Impaired dopamine release and synaptic plasticity in the striatum of Parkin−/− mice , 2009, Journal of neurochemistry.

[67]  祐輝 橋本谷,et al.  Phospholipase Cβ serves as a coincidence detector through its Ca[2+] dependency for triggering retrograde endocannabinoid signal , 2005 .

[68]  A. Saghatelian,et al.  Inactivation of N-acyl phosphatidylethanolamine phospholipase D reveals multiple mechanisms for the biosynthesis of endocannabinoids. , 2006, Biochemistry.